Reports for IRBESARTAN
Ingredient
IRBESARTAN
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TARO-IRBESARTAN | 300MG | TABLET | Resolved | 2019-02-15 | 2021-06-16 | 75896 |
TEVA-IRBESARTAN | 150MG | TABLET | Resolved | 2017-08-14 | 2017-09-19 | 19308 |
TEVA-IRBESARTAN HCTZ | 12.5MG 300MG | TABLET | Resolved | 2017-05-10 | 2017-09-19 | 9785 |
SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2022-09-21 | 2022-10-20 | 169691 |
SANDOZ IRBESARTAN | 75MG | TABLET | Resolved | 2023-10-02 | 2024-02-01 | 205797 |
SANDOZ IRBESARTAN | 150MG | TABLET | Resolved | 2023-10-23 | 2023-10-31 | 207764 |
SANDOZ IRBESARTAN | 300MG | TABLET | Resolved | 2020-11-09 | 2020-11-28 | 128158 |
SANDOZ IRBESARTAN | 300MG | TABLET | Resolved | 2023-04-11 | 2023-05-16 | 189223 |
SANDOZ IRBESARTAN | 300MG | TABLET | Resolved | 2023-06-05 | 2023-07-18 | 193723 |
SANDOZ IRBESARTAN HCT | 150MG 12.5MG | TABLET | Resolved | 2020-09-21 | 2020-10-27 | 124600 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40766 |
APO-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40769 |
AVAPRO | 75MG | TABLET | To be discontinued | 2024-05-31 | 2024-05-31 | 229306 |
MINT-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143956 |
MINT-IRBESARTAN/HCTZ | 12.5MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143952 |
MINT-IRBESARTAN/HCTZ | 25MG 300MG | TABLET | Discontinued | 2021-08-11 | 2021-08-11 | 143959 |
MYLAN-IRBESARTAN | 75MG | TABLET | Discontinued | 2018-04-04 | 2018-08-01 | 44870 |
MYLAN-IRBESARTAN | 150MG | TABLET | Discontinued | 2018-04-04 | 2018-08-11 | 44867 |